Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Vasoconstrictor eicosanoids and impaired microvascular function in inactive and insulin-resistant primates

International Journal of Obesity volume 40, pages 1600–1603 (2016)Cite this article

Subjects

Abstract

The inability to augment capillary blood volume (CBV) in response to insulin or glucose is thought to contribute to insulin resistance (IR) by limiting glucose uptake in key storage sites. Understanding the mechanisms that contribute to impaired CBV augmentation early in the onset of IR may lead to new future therapies. We hypothesized that inactivity alters the balance of vasoactive eicosanoids and contributes to microvascular IR. In ten activity-restricted (AR) and six normal activity adult male rhesus macaques, contrast-enhanced ultrasound of skeletal muscle blood flow and CBV was performed at baseline and during intravenous glucose tolerance test (IVGTT). Plasma was analyzed for vasoconstrictor hydroxyeicosatetraenoic acids (HETEs) and the ratio of vasodilatory epoxyeicosatrienoic acids (EETs) to their less biologically active dihydroxyeicosatrienoic acids (DHETs) as an indirect measure of soluble epoxide hydrolase activity. AR primates were IR during IVGTT and had a 45% lower glucose-stimulated CBV response. Vasoconstrictor 18-HETE and 19-HETE and the DHET/EET ratio were markedly elevated in the AR group and correlated inversely with the CBV response. In addition, levels of 18-HETE and 19-HETE correlated directly with microvascular IR. We conclude that a shift toward increased eicosanoid vasoconstrictor tone correlates with abnormal skeletal muscle vascular recruitment and may contribute to IR.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Coggins M, Lindner J, Rattigan S, Jahn L, Fasy E, Kaul S et al. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 2001; 50: 2682–2690.

    Article  CAS  Google Scholar 

  2. Vincent MA, Clerk LH, Lindner JR, Price WJ, Jahn LA, Leong-Poi H et al. Mixed meal and light exercise each recruit muscle capillaries in healthy humans. Am J Physiol Endocrinol Metab 2006; 290: E1191–E1197.

    Article  CAS  Google Scholar 

  3. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P . Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994; 94: 2511–2515.

    Article  CAS  Google Scholar 

  4. Solomon TP, Haus JM, Li Y, Kirwan JP . Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability. J Clin Endocrinol Metab 2011; 96: 1377–1384.

    Article  CAS  Google Scholar 

  5. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD . Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172–1179.

    Article  CAS  Google Scholar 

  6. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S . Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 2003; 285: E123–E129.

    Article  CAS  Google Scholar 

  7. Vincent MA, Clerk LH, Lindner JR, Klibanov AL, Clark MG, Rattigan S et al. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 2004; 53: 1418–1423.

    Article  CAS  Google Scholar 

  8. Laakso M, Edelman SV, Brechtel G, Baron AD . Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990; 85: 1844–1852.

    Article  CAS  Google Scholar 

  9. Clerk LH, Vincent MA, Barrett EJ, Lankford MF, Lindner JR . Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. Am J Physiol Endocrinol Metab 2007; 293: E1804–E1809.

    Article  CAS  Google Scholar 

  10. Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ . Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 2006; 55: 1436–1442.

    Article  CAS  Google Scholar 

  11. Chadderdon SM, Belcik JT, Smith E, Pranger L, Kievit P, Grove KL et al. Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates. Am J Physiol Endocrinol Metab 2012; 303: E607–E613.

    Article  CAS  Google Scholar 

  12. Iyer A, Kauter K, Alam MA, Hwang SH, Morisseau C, Hammock BD et al. Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp Diabetes Res 2012; 2012: 1–11.

    Article  Google Scholar 

  13. Luria A, Bettaieb A, Xi Y, Shieh GJ, Liu HC, Inoue H et al. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci USA 2011; 108: 9038–9043.

    Article  CAS  Google Scholar 

  14. Mustafa S, Sharma V, McNeill JH . Insulin resistance and endothelial dysfunction: are epoxyeicosatrienoic acids the link? Exp Clin Cardiol 2009; 14: e41–e50.

    PubMed  PubMed Central  Google Scholar 

  15. Shim CY, Kim S, Chadderdon S, Wu M, Qi Y, Xie A et al. Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume. Am J Physiol Endocrinol Metab 2014; 307: E1097–E1104.

    Article  CAS  Google Scholar 

  16. Roche C, Besnier M, Cassel R, Harouki N, Coquerel D, Guerrot D et al. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice. Am J Physiol Heart Circ Physiol 2015; 308: H1020–H1029.

    Article  CAS  Google Scholar 

  17. Fleming I . Cytochrome p450 and vascular homeostasis. Circ Res 2001; 89: 753–762.

    Article  CAS  Google Scholar 

  18. Roman RJ . P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82: 131–185.

    Article  CAS  Google Scholar 

  19. Hamburg NM, McMackin CJ, Huang AL, Shenouda SM, Widlansky ME, Schulz E et al. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol 2007; 27: 2650–2656.

    Article  CAS  Google Scholar 

  20. Nosova EV, Yen P, Chong KC, Alley HF, Stock EO, Quinn A et al. Short-term physical inactivity impairs vascular function. J Surg Res 2014; 190: 672–682.

    Article  Google Scholar 

Download references

Acknowledgements

Dr Chadderdon was funded by a Fellow-to-Faculty Award (0875005N) from the American Heart Association and grant 5KL2TR000152 from the National Institutes of Health (NIH). Dr Lindner is supported by grants, R01-HL-078610 and R01-HL-111969 from the NIH. Dr Grove is supported by grant R01-DK-79194 from the NIH. The Oregon National Primate Research Center is supported by a National Center for Research Resources grant (S10-RR-024585) and a Research Program Projects and Centers grant (P51 DK011092) from the NIH. This publication was made possible with support from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1 RR024140 from the National Center for Advancing Translational Sciences, a component of the NIH and NIH Roadmap for Medical Research.

Author information

Authors and Affiliations

  1. Knight Cardiovascular Institute,

    S M Chadderdon, J T Belcik & J R Lindner

  2. Oregon Health & Science University, Portland, OR, USA

    S M Chadderdon, J T Belcik & J R Lindner

  3. The Oregon National Primate Research Center,

    L Bader, P Kievit & K L Grove

  4. Oregon Health & Science University, Portland, OR, USA

    L Bader, P Kievit & K L Grove

Authors
  1. S M Chadderdon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J T Belcik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Kievit
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K L Grove
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J R Lindner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S M Chadderdon.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chadderdon, S., Belcik, J., Bader, L. et al. Vasoconstrictor eicosanoids and impaired microvascular function in inactive and insulin-resistant primates. Int J Obes 40, 1600–1603 (2016). https://doi.org/10.1038/ijo.2016.117

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2016.117

This article is cited by

Search

Advanced search

Quick links